Expertise in
16
conditions

Dr. Jason B. Fleming

General Surgery
UT Southwestern Medical Center
1801 Inwood Rd, 
Dallas, TX 
Offers Telehealth
Expertise in
16
conditions
UT Southwestern Medical Center
1801 Inwood Rd, 
Dallas, TX 

Overview

Jason Fleming is a General Surgeon practicing medicine in Dallas, Texas.

Dr. Fleming is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, Neuroendocrine Tumor, Pancreaticoduodenectomy, and Pancreatectomy.

He is actively involved in clinical research, co-authoring 271 peer reviewed articles and participating in 8 clinical trials.

Specialties

General Surgery

Licenses

Surgery in TX

Hospital Affiliations

UT Of Texas Southwestern University Hospital - William P. Clements Jr.

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D

Locations

UT Southwestern Medical Center
1801 Inwood Rd, Dallas, TX 75235
Other Locations
Urology of Virginia PLLC
12902 Usf Magnolia Dr, Tampa, FL 33612

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Gastroesophageal Cancer (GEC) Patients
Support Through Remote Observation and Nutrition Guidance (STRONG) Program for Gastroesophageal Cancer (GEC) Patients
Enrollment Status: Completed
Publish Date: July 30, 2026
Intervention Type: Behavioral
Study Phase: Not Applicable
The Florida Pancreas Collaborative Next-Generation Biobank: Reducing Health Disparities and Improving Survival for Pancreatic Cancer
The Florida Pancreas Collaborative Next-Generation Biobank: Reducing Health Disparities and Improving Survival for Pancreatic Cancer
Enrollment Status: Active_not_recruiting
Publish Date: June 26, 2026
Intervention Type: Other
Randomized Trial of Prolonged Use of Negative Pressure Wound Therapy in Patients Undergoing Surgical Procedures for the Management of Gastrointestinal Malignancies
Randomized Trial of Prolonged Use of Negative Pressure Wound Therapy in Patients Undergoing Surgical Procedures for the Management of Gastrointestinal Malignancies
Enrollment Status: Completed
Publish Date: June 09, 2026
Intervention Type: Device
Study Phase: Phase 2/Phase 3
Early Supportive Care and Nutritional Support in Adults With Pancreatic Cancer
Early Supportive Care and Nutritional Support in Adults With Pancreatic Cancer
Enrollment Status: Completed
Publish Date: March 31, 2026
Intervention Type: Behavioral
Study Phase: Not Applicable
Mobile APP Utilization for Enhanced Post-Operative Nutritional Recovery
Mobile APP Utilization for Enhanced Post-Operative Nutritional Recovery
Enrollment Status: Completed
Publish Date: April 11, 2023
Intervention Type: Other
Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy
Long Term Follow-Up Study for Subjects Previously Treated With Algenpantucel-L (HyperAcute-Pancreas) Immunotherapy
Enrollment Status: Terminated
Publish Date: April 12, 2022
Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer: Establishing the Radiomic/Pathologic Foundation of Heterogeneity
Total Tumor Mapping (TTM) for Resectable Pancreatic Cancer: Establishing the Radiomic/Pathologic Foundation of Heterogeneity
Enrollment Status: Withdrawn
Publish Date: February 08, 2021
Intervention Type: Procedure, Drug
Study Phase: Early Phase 1
Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas
Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas
Enrollment Status: Terminated
Publish Date: May 02, 2019
Intervention Type: Drug
Study Phase: Early Phase 1
View 7 Less Clinical Trials

271 Total Publications

Author Correction: Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer.
Author Correction: Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer.
Journal: Nature
Published: August 18, 2026
Similar Doctors
Expertise in
26
conditions
Dr. Adam C. Yopp
General Surgery
Expertise in
26
conditions
Dr. Adam C. Yopp
General Surgery
Referral may be required

Dallas County Hospital District

5200 Harry Hines Blvd, 
Dallas, TX 
 (0.7 miles away)
214-590-8000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Adam Yopp is a General Surgeon practicing medicine in Dallas, Texas. Dr. Yopp is highly rated in 26 conditions, according to our data. His clinical expertise encompasses Liver Cancer, Adrenocortical Carcinoma, Fibrolamellar Carcinoma, Hepatectomy, and Pancreaticoduodenectomy.

Expertise in
61
conditions
Dr. Dhiresh R. Jeyarajah
General Surgery
Expertise in
61
conditions
Dr. Dhiresh R. Jeyarajah
General Surgery
Referral may be required
Before you request

MedHealth

2805 E President George Bush Turnpike, 
Richardson, TX 
 (16.1 miles away)
469-726-6100
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Dhiresh Jeyarajah is a General Surgeon practicing medicine in Richardson, Texas. Dr. Jeyarajah is highly rated in 61 conditions, according to our data. His clinical expertise encompasses Hiatal Hernia, Hernia, Pancreatic Cancer, Pancreaticoduodenectomy, and Pancreatectomy. Dr. Jeyarajah is board certified in General Surgery- American Board Of Surgery/General Surgery, - American Board Of Surgery/General Surgery, and General Surgery- American Board Of Surgery. Dr. Jeyarajah is currently accepting new patients.

Expertise in
40
conditions
Dr. John C. Mansour
General Surgery
Expertise in
40
conditions
Dr. John C. Mansour
General Surgery
Referral may be required

University Of Texas Southwestern Medical Center

5323 Harry Hines Blvd, 
Dallas, TX 
 (0.4 miles away)
214-648-3111
Languages Spoken:
English
See accepted insurances
Offers Telehealth

John Mansour is a General Surgeon practicing medicine in Dallas, Texas. Dr. Mansour is highly rated in 40 conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Adrenocortical Carcinoma, Stomach Cancer, Pancreatectomy, and Pancreaticoduodenectomy.

Frequently Asked Questions about Dr. Jason B. Fleming

How do I make an appointment with Dr. Jason B. Fleming?

You can book an appointment with Dr. Jason B. Fleming by calling their office at 214-645-2900. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Jason B. Fleming a top-rated expert for Pancreatic Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Jason B. Fleming is classified as an Elite expert for Pancreatic Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Jason B. Fleming specialize in?

While Dr. Jason B. Fleming is a General Surgery, they have specific expertise in Pancreatic Cancer, Pancreatic Ductal Adenocarcinoma, and Pancreaticoduodenectomy. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within General Surgery.

Does Dr. Jason B. Fleming participate in research or clinical trials?

Yes. Dr. Jason B. Fleming has published 271 articles and abstracts on conditions like Pancreatic Cancer. You can view a list of Dr. Jason B. Fleming's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Jason B. Fleming accept my insurance?

Dr. Jason B. Fleming accepts most major insurance plans, including Blue Cross Blue Shield and Humana. We recommend calling the office directly at 214-645-2900 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Fleming's expertise for a condition
ConditionClose
View All 9 Advanced Conditions
View All 39 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile